Motilal Oswal S&P BSE Healthcare ETF - Growth - Regular Plan

Other Plans and Options
  • 1.13 %Nav, as on 27-09-2023

  • Previous Nav

  • Net Change on 27-09-2023

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 1.58 10.96 24.19 13.82 13.77 14.19

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Nifty 50 ETF Jul 22, 2015 16.69 22.53 13.40 0.04 158,951.80
SBI S&P BSE SENSEX ETF Mar 15, 2013 16.86 22.19 13.81 0.04 96,329.08
Nippon India ETF Nifty 50 BeES Dec 28, 2001 16.72 22.56 13.44 0.04 14,110.10
ICICI Prudential Nifty 50 ETF Mar 20, 2013 16.73 22.57 13.43 0.03 6,701.95
Nippon India ETF Nifty Bank BeES May 27, 2004 16.35 29.17 11.98 0.19 5,808.24

Fund Holdings as on 31-August-2023

  • Sun Pharmaceutical Industries Limited

  • Dr. Reddy's Laboratories Limited

  • Cipla Limited

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Lupin Limited

  • Aurobindo Pharma Limited

  • Torrent Pharmaceuticals Limited

  • Fortis Healthcare Limited

  • Zydus Lifesciences Limited

  • Laurus Labs Limited

  • Alkem Laboratories Limited

  • Abbott India Limited

  • Gland Pharma Limited

  • Biocon Limited

  • IPCA Laboratories Limited

  • Glenmark Pharmaceuticals Limited

  • Syngene International Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Natco Pharma Limited

  • Dr. Lal Path Labs Limited

  • Krishna Institute Of Medical Sciences Limited

  • Narayana Hrudayalaya Limited

  • Poly Medicure Limited

  • Sanofi India Limited

  • Ajanta Pharma Limited

  • Piramal Pharma Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Pfizer Limited

  • Aster DM Healthcare Limited

  • Suven Pharmaceuticals Limited

  • Alembic Pharmaceuticals Limited

  • Granules India Limited

  • Procter & Gamble Health Limited

  • Global Health Limited

  • Jubilant Pharmova Limited

  • Metropolis Healthcare Limited

  • Neuland Laboratories Limited

  • Rainbow Childrens Medicare Limited

  • Strides Pharma Science Limited

  • AstraZeneca Pharma India Limited

  • Caplin Point Laboratories Limited

  • Eris Lifesciences Limited

  • Vijaya Diagnostic Centre Limited

  • Marksans Pharma Limited

  • Aarti Drugs Limited

  • FDC Limited

  • Sun Pharma Advanced Research Company Limited

  • Net Receivables / (Payables)

  • Unichem Laboratories Limited

  • Glenmark Life Sciences Limited

  • Healthcare Global Enterprises Limited

  • Shilpa Medicare Limited

  • Kovai Medical Center and Hospital Limited

  • Ami Organics Limited

  • Advanced Enzyme Technologies Limited

  • Indoco Remedies Limited

  • Wockhardt Limited

  • Hikal Limited

  • Sequent Scientific Limited

  • Dishman Carbogen Amcis Limited

  • Morepen Laboratories Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Thyrocare Technologies Limited

  • Tarsons Products Limited

  • Krsnaa Diagnostics Limited

  • Gufic Biosciences Limited

  • Supriya Lifescience Limited

  • Indraprastha Medical Corporation Limited

  • Hester Biosciences Limited

  • Shalby Limited

  • Solara Active Pharma Sciences Limited

  • Kopran Limited

  • Bliss GVS Pharma Limited

  • RPG Life Sciences Limited

  • Lincoln Pharmaceuticals Limited

  • Novartis India Limited

  • Suven Life Sciences Limited

  • Themis Medicare Limited

  • Vimta Labs Limited

  • Syncom Formulations India Limited

  • MEDICAMEN BIOTECH LIMITED

  • Artemis Medicare Services Limited

  • KMC Speciality Hospitals (India) Limited

  • NGL Fine Chem Limited

  • Jagsonpal Pharmaceuticals Limited

  • SMS Pharmaceuticals Limited

  • Bajaj Healthcare Limited

  • Windlas Biotech Limited

  • Gujarat Themis Biosyn Limited

  • Sigachi Industries Limited

  • Sastasundar Ventures Limited

  • Anuh Pharma Limited

  • Venus Remedies Limited

  • Nectar Lifesciences Limited

  • Take Solutions Limited

  • Fermenta Biotech Limited

  • Panacea Biotec Limited

  • Nureca Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Plastic Products

  • Trading

  • Chemicals

  • Finance - NBFC

  • IT - Software

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal S&P BSE Healthcare ETF

Scheme Analysis

Motilal Oswal S&P BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹7.84 crore. Motilal Oswal S&P BSE Healthcare ETF is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of Motilal Oswal S&P BSE Healthcare ETF ended up ₹0.31(1.13%)yesterday to ₹28.258.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal S&P BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022-39804238
022-22816161